The efficacy and safety of different long-acting β2-agonists combined with inhaled glucocorticoid regimens in patients with asthma: a network meta-analysis

References

• GINA. Global strategy for asthma management and prevention updated 2017.
   Google Scholar
• Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011;128:315–322.
   PubMed Web of Science ®Google Scholar
• Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database of Systematic Reviews 2015;11:CD007949.
   Google Scholar
• Castro-Rodriguez JA, Rodrigo GJ. A systematic review of long-acting β2-agonists versus higher doses of inhaled corticosteroids in asthma . Pediatrics 2012;130:e650–e657.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009;373:746–758.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sheng J, Yang Y, Fang W, Kang S, He Y, Hong S, Zhan J, Zhao Y, Xue C, et al. Optimized selection of three major EGFR-TKIs in advanced EGFR-positive non-small cell lung cancer: a network metaanalysis. Oncotarget 2016;7:20093–20108.
   Google Scholar
• Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004;23:3105–3124.
   PubMed Web of Science ®Google Scholar
• Jansen JP, Crawford B, Bergman G, Stam W. Bayesian metaanalysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health 2008;11:956–964.
   PubMed Web of Science ®Google Scholar
• Catalá-López F, Tobías A, Cameron C, Moher D, Hutton B. Network meta-analysis for comparing treatment effects of multiple interventions: an introduction. Rheumatol Int 2014;34:1489–1496.
   PubMed Web of Science ®Google Scholar
• Ying T, Zhigang Z, Caiyun Z, Jinhui T, Long G, Efficacy and safety of long-acting ß2 agonist combined with inhaled glucocorticoid in asthmatic patients: a network meta-analysis. PROSPERO 2017:CRD42017060864. Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42017060864
   Google Scholar
• Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from: www.cochranehandbook.org [last accessed 9 May 2014].
   Google Scholar
• Dias S, Welton NJ, Sutton AJ, Ades AE. NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. London, UK: National Institute for Health and Clinical Excellence; 2011.
   Google Scholar
• Chen YH, Du L, Geng XY, Peng YL, Shen JN, Zhang YG, Liu GJ, Sun X. Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials . J Evid Based Med 2015;8:134–148.
   PubMedGoogle Scholar
• Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JPA, Straus S, Thorlund K, Jansen JP, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Internal Med 2015;162:777–784.
   PubMed Web of Science ®Google Scholar
• Papi A, Paggiaro P, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007;29:682–689.
   PubMed Web of Science ®Google Scholar
• Maspero JF, Nolte H, Chérrez-Ojeda I, P04139 Study Group Long-term safety of Mometasone Furoate/Formoterol combination for treatment of patients with persistent asthma. J Asthma 2010;47:1106–1115.
   PubMed Web of Science ®Google Scholar
• Kuna P. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged ≥16 years with asthma: post hoc analysis of a randomized, double-blind study. Clin Drug Investig 2010;30:565–579.
   PubMed Web of Science ®Google Scholar
• Bodzenta-Lukaszyk A, Buhl R, Balint B, Lomax M, Spooner K, Dissanayake S. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety. J Asthma 2012;49:1060–1070.
   PubMedGoogle Scholar
• Lin J-T, Chen P, Zhou X, Sun T-Y, Xie CM, Xiu QY, Yao WZ, Yang L, Yin KS, Zhang YM. Budesonide/formoterol maintenance and reliever therapy in Chinese patients with asthma. Chin Med J 2012;17:2994–3001.
   Google Scholar
• Emeryk A, Klink R, McIver T, Dalvi P. A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma. Therap Adv Respir Dis 2016;10:324–337.
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Hébert J, Cheema A, Murphy KR, Chérrez-Ojeda I, Matiz-Bueno C, Kuo W-L, Nolte H. Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma. Allergy Asthma Clin Immunol 2011;7:21.
   PubMed Web of Science ®Google Scholar
• Bodzenta-Lukaszyk A, Dymek A, McAulay K, Mansikka H. Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study. BMC Pulmon Med 2011;11:28.
   PubMed Web of Science ®Google Scholar
• Papi A, Paggiaro PL, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007;29:682–689.
   PubMed Web of Science ®Google Scholar
• Kirsten A-M, Watz H, Brindicci C, Piccinno A, Magnussen H. Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma—an exploratory study. Pulmon Pharmacol Therap 2015;31:79–84.
   PubMed Web of Science ®Google Scholar
• Cukier A, Jacob CMA, Rosario Filho NA, Fiterman J, Vianna EO, Hetzel JL, Neis MA, Fiss E, Castro FF, Fernandes AL, et al. Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma. Respir Med 2013;107:1330–1338.
   PubMed Web of Science ®Google Scholar
• Korn S, Buhl R. Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study. Respir Med 2012;106:57–67.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Boulet L-P, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A, et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med 2007;101:2437–2446.
   PubMed Web of Science ®Google Scholar
• Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R. EXCEL: a randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Respir Med 2006;100:1152–1162.
   PubMed Web of Science ®Google Scholar
• FitzGerald JM, Boulet LP, Follows RMA. The CONCEPT trial: a 1-year, multicenter, randomized, double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. Clin Therap 2005;27:393–406.
   PubMed Web of Science ®Google Scholar
• Woodcock A, Bleecker ER, Lötvall J, O'Byrne PM, Bateman ED, Medley H, Ellsworth A, Jacques L, Busse WW. Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial. Chest 2013;144:1222–1229.
   PubMed Web of Science ®Google Scholar
• Antilla M, Castro F, Cruz Á, Rubin A, Rosário N, Stelmach R. Efficacy and safety of the single-capsule combination of fluticasone/formoterol in patients with persistent asthma: a non-inferiority trial*. J Bras Pneumol 2014; 40:599–608.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Han S, Shang J, Zhao X, Pu R, Shi L. Effectiveness of drug treatment strategies to prevent asthma exacerbations and increase symptom-free days in asthmatic children: a network meta-analysis. J Asthma 2015;52:846–857.
   PubMed Web of Science ®Google Scholar
• Tamm M, Richards DH, Beghé B, Fabbri L. Inhaled corticosteroid and long-acting b2-agonist pharmacological profiles: effective asthma therapy in practice. Respir Med 2012;106:S9–S19.
   PubMed Web of Science ®Google Scholar
• Chikina SY. Fluticasione furoate/vilanterol combination (Relvar Ellipta®) in bronchial asthma: a review of clinical trials. Pulmonologiya 2015;25:622–627.
   Google Scholar
• Cates CJ, Lasserson TJ. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2010;1:CD007694.
   Google Scholar
• Dissanayake S, Grothe B, Kaiser K. Fluticasone/formoterol: a new single-aerosol combination therapy for patients with asthma. Respir Med 2012;106:S20–S28.
   PubMed Web of Science ®Google Scholar